09:00-09:15 Official opening
09:15-09:40 Tobias Bald
University of Bonn, Germany
09:40-10:05 Kazuyo Moro
RIKEN/Osaka University, Japan
The Impact of Appendectomy on Ulcerative Colitis
10:05-10:30 Jakub Gołąb
Medical University of Warsaw, Poland
The roles of arginases in mitigation of antitumor immunity
10:30-10:55 Aurélie Poli
Luxembourg Institute of Health
AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
10:55-11:20 Alexandros Drainas
BioMed X, Germany
The quest to eliminate ecDNA in cancer cells
11:20-11:40 Break
11:40-12:05 SĂ©bastien Talbot (online)
Queen’s University Ontario, Canada
Peripheral Nerve Injury Induced by Colorectal Cancer: Mechanisms and Implications for Chemotherapy-Induced Peripheral Neuropathy
12:05-12:30 Hrvoje Miletic

University of Bergen, Norway Cell communication and mitochondria transfer in brain tumors
12:30-12:55 Anne-Marie Heegaard
University of Copenhagen, Denmark
Pain in Multiple Myeloma – interaction of the cancer microenvironment with the sensory nervous system
12:55-13:20 Andrew Shepherd
University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Pain neurons control cancer immunosurveillance
13:20-14:30 Break
14:30-14:55 Claudio Ballabio
The Francis Crick Institute, London, United Kingdom
Tumour intrinsic electrical activity drives small-cell lung cancer progression
14:55-15:20 Yuan Pan
Phd, Assistant Professor in the Department of Symptom Research at the University of Texas MD Anderson Cancer Center
The Cancer Neuroscience of Neurofibromatosis type 1 (NF1)
15:20-15:45 Dominika Nowis
University of Texas MD Anderson Cancer Center, Houston, Texas, USA
The use of mRNA-based immunotherapies in experimental oncology
15:45-16:10 Helena Florindo
University of Lisbon, Portugal
Unveiling Solid Tumor Microenvironment for revolutionary nano-immunotherapies
16:10-17:00 Break
17:00-18:00 Opening Keynote Melody Swartz
University of Chicago, USA
The yin and yang of tumor-associated lymphatics in metastasis and anti-tumor immunity

09:00-09:25 Carlos-Filipe Pereira
Lund University, Sweden
Empowering Cancer Immunotherapy with Cellular Reprogramming
09:25-09:50 Rafael Blanco DomĂ­nguez
University of Lisbon, Portugal
Delta One T cells in Cancer Immunotherapy
09:50-10:15 Helen Kakkassery
King’s College London, United Kingdom
Investigating the immune surveillance mechanisms in atypical responders of stage IV breast cancers following standard of care chemo – and targeted therapies
10:15-10:40 Thanussuyah Alaguthurai
King’s College London, United Kingdom
Translational Research Programme- Facilitating oncology research at Guy’s
10:40-11:05 Marco Gustav
Dresden University of Technology, Germany
Deep Learning-based Biomarkers for Precision Oncology
11:05-11:25 Break
11:25-11:50 Christoph Klose
Charite – Berlin University Medicine, Germany
Neuro-immune interactions at barrier surfaces
11:50-12:15 Varun Venkataramani
Heidelberg University, Germany
12:15-13:15 EIT Health Morning Talks
13:15-14:15 Company session
14:15-14:30 Official closure
14:30-15:30 Lunch
Skip to content